Medpace Holdings, Inc. Common Stock
Medpace Holdings, Inc. Common Stock price
About Medpace Holdings, Inc. Common Stock
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Stock ticker
- MEDP
- Company
- Medpace Holdings, Inc.
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- --
- Launch date
- Aug 11, 2016
- Listed exchange
- NASDAQ
Financials
Summary: MEDP reported Revenue of 707.33M (+17.24%), beating expectations; EPS of 4.25 (+37.10%), beating expectations.
Medpace Holdings, Inc. Common Stock conversion tables
 |  |
|---|---|
| 0.5 MEDP | 301.48 USD |
| 1 MEDP | 602.96 USD |
| 5 MEDP | 3,014.8 USD |
| 10 MEDP | 6,029.6 USD |
| |
|---|---|
| 0.5 USD | 0.00082924 MEDP |
| 1 USD | 0.0016585 MEDP |
| 5 USD | 0.0082924 MEDP |
| 10 USD | 0.016585 MEDP |
More to explore
FAQ
MEDP is trading at $602.96, -0.21% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MEDP stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MEDP is currently trading at $602.96, -0.21% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MEDP price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MEDP's P/E ratio is currently 34.66 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MEDP; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MEDP's historical range and other companies in the Healthcare sector.
Medpace Holdings, Inc.'s market cap is currently 16.51B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.